1 – 19 of 19
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept : Results from the international TOCERRA and PANABA observational collaborative studies
(
- Contribution to journal › Article
-
Mark
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
(
- Contribution to journal › Article
-
Mark
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor : results from 13 European registries
(
- Contribution to journal › Article
-
Mark
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis : Results From the European Spondyloarthritis Research Collaboration Network
(
- Contribution to journal › Article
-
Mark
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis : a European routine-care observational study
(
- Contribution to journal › Article
- 2023
-
Mark
The effect of charcoal production on carbon cycling in African biomes
(
- Contribution to journal › Article
-
Mark
Global change scenarios in coastal river deltas and their sustainable development implications
(
- Contribution to journal › Article
-
Mark
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
(
- Contribution to journal › Scientific review
-
Mark
Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis : Results from the EuroSpA Research Collaboration Network
(
- Contribution to journal › Article
- 2022
-
Mark
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors : Data from the EuroSpA collaboration
(
- Contribution to journal › Article
-
Mark
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
(
- Contribution to journal › Article
- 2019
-
Mark
Benefits for multiple ecosystem services in Peruvian coffee agroforestry systems without reducing yield
(
- Contribution to journal › Article
-
Mark
Imputing missing data of function and disease activity in rheumatoid arthritis registers : What is the best technique?
(
- Contribution to journal › Article
- 2018
-
Mark
Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Effects of dual administration of liraglutide and ghrelin on brain mitochondrial metabolism in the r6/2 mouse
2018) European Huntington Disease Network conference 2018 In Journal of Neurology, Neurosurgery and Psychiatry 89(Suppl 1). p.92-92(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
L23 Effects of peripheral (co-)administration of liraglutide and ghrelin in the R6/2 mouse brain function
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1). p.98-98(
- Contribution to journal › Published meeting abstract
-
Mark
Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis : Dose-Dependent Expression and Improved Retinal Structure and Function
(
- Contribution to journal › Article
- 2014
-
Mark
Primary and secondary glomerulonephritides 1.
2014) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 29 Suppl 3(May). p.186-200(
- Contribution to journal › Article
- 2002
-
Mark
Synthetic, spectroscopic, and X-ray crystallographic studies of [1,2,7,8]tetrathiacyclododecino[4,3-b : 5,6-b': 10,9-b": 11,12-b''']tetraindoles
(
- Contribution to journal › Article